These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16134092)

  • 21. Dosage-dependent translational suppression in yeast Saccharomyces cerevisiae.
    Chernoff YO; Inge-Vechtomov SG; Derkach IL; Ptyushkina MV; Tarunina OV; Dagkesamanskaya AR; Ter-Avanesyan MD
    Yeast; 1992 Jul; 8(7):489-99. PubMed ID: 1523883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of termination mutations caused by defects of the NMD machinery in Saccharomyces cerevisiae.
    Ono B; Yoshida R; Kamiya K; Sugimoto T
    Genes Genet Syst; 2005 Oct; 80(5):311-6. PubMed ID: 16394582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism by which overexpression of Gts1p induces flocculation in a FLO8-inactive strain of the yeast Saccharomyces cerevisiae.
    Shen H; Iha H; Yaguchi S; Tsurugi K
    FEMS Yeast Res; 2006 Sep; 6(6):914-23. PubMed ID: 16911513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of NMD increases viability of sup45 nonsense mutants in Saccharomyces cerevisiae.
    Chabelskaya S; Gryzina V; Moskalenko S; Le Goff C; Zhouravleva G
    BMC Mol Biol; 2007 Aug; 8():71. PubMed ID: 17705828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive and negative transcriptional regulation by the yeast GAL11 protein depends on the structure of the promoter and a combination of cis elements.
    Nishizawa M; Taga S; Matsubara A
    Mol Gen Genet; 1994 Nov; 245(3):301-12. PubMed ID: 7816040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae.
    Suzuki Y; Nogi Y; Abe A; Fukasawa T
    Mol Cell Biol; 1992 Oct; 12(10):4806. PubMed ID: 1406662
    [No Abstract]   [Full Text] [Related]  

  • 27. GAL11P: a yeast mutation that potentiates the effect of weak GAL4-derived activators.
    Himmelfarb HJ; Pearlberg J; Last DH; Ptashne M
    Cell; 1990 Dec; 63(6):1299-309. PubMed ID: 2124519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast GAL11 protein stimulates basal transcription in a gene-specific manner by a mechanism distinct from that by DNA-bound activators.
    Sakurai H; Ohishi T; Amakasu H; Fukasawa T
    FEBS Lett; 1994 Sep; 351(2):176-80. PubMed ID: 8082760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GAL recombinant yeast strain for enhanced protein production.
    Stagoj MN; Comino A; Komel R
    Biomol Eng; 2006 Sep; 23(4):195-9. PubMed ID: 16707274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsense-mediated mRNA decay mutation in Aspergillus nidulans.
    Morozov IY; Negrete-Urtasun S; Tilburn J; Jansen CA; Caddick MX; Arst HN
    Eukaryot Cell; 2006 Nov; 5(11):1838-46. PubMed ID: 16963627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gal11p dosage-compensates transcriptional activator deletions via Taf14p.
    Lim MK; Tang V; Le Saux A; Schüller J; Bongards C; Lehming N
    J Mol Biol; 2007 Nov; 374(1):9-23. PubMed ID: 17919657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GAL11 (SPT13), a transcriptional regulator of diverse yeast genes, affects the phosphorylation state of GAL4, a highly specific transcriptional activator.
    Long RM; Mylin LM; Hopper JE
    Mol Cell Biol; 1991 Apr; 11(4):2311-4. PubMed ID: 2005915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that Gal11 protein is a target of the Gal4 activation domain in the mediator.
    Jeong CJ; Yang SH; Xie Y; Zhang L; Johnston SA; Kodadek T
    Biochemistry; 2001 Aug; 40(31):9421-7. PubMed ID: 11478912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saccharomyces cerevisiae Med9 comprises two functionally distinct domains that play different roles in transcriptional regulation.
    Takahashi H; Kasahara K; Kokubo T
    Genes Cells; 2009 Jan; 14(1):53-67. PubMed ID: 19077037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proline-dependent transcription factor Put3 regulates the expression of the riboflavin transporter MCH5 in Saccharomyces cerevisiae.
    Spitzner A; Perzlmaier AF; Geillinger KE; Reihl P; Stolz J
    Genetics; 2008 Dec; 180(4):2007-17. PubMed ID: 18940788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genome-wide analysis of transcriptional effect of Gal11 in Saccharomyces cerevisiae: an application of "mini-array hybridization technique".
    Fukasawa T; Fukuma M; Yano K; Sakurai H
    DNA Res; 2001 Feb; 8(1):23-31. PubMed ID: 11258797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of Yap1 towards Saccharomyces cerevisiae adaptation to arsenic-mediated oxidative stress.
    Menezes RA; Amaral C; Batista-Nascimento L; Santos C; Ferreira RB; Devaux F; Eleutherio EC; Rodrigues-Pousada C
    Biochem J; 2008 Sep; 414(2):301-11. PubMed ID: 18439143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activator Gcn4p and Cyc8p/Tup1p are interdependent for promoter occupancy at ARG1 in vivo.
    Kim SJ; Swanson MJ; Qiu H; Govind CK; Hinnebusch AG
    Mol Cell Biol; 2005 Dec; 25(24):11171-83. PubMed ID: 16314536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of N-terminal domain of translational release factor eRF3 for the control of functionality and stability in S. cerevisiae.
    Kodama H; Ito K; Nakamura Y
    Genes Cells; 2007 May; 12(5):639-50. PubMed ID: 17535254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of yeast NRD1 expression by premature transcription termination.
    Arigo JT; Carroll KL; Ames JM; Corden JL
    Mol Cell; 2006 Mar; 21(5):641-51. PubMed ID: 16507362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.